Pharmacy Times

In modern healthcare, transformational success begins with strategic collaboration. This #NationalPharmacistDay, we celebrate pharmacists as essential partners in clinical decision-making and treatment innovation, advancing patient care from cardiovascular medicine to oncology and beyond. How are these partnerships elevating care at leading institutions? #SneakPeek: stay tuned to hear from Dr. Erica Mayer, MD, MPH of Dana-Farber Cancer Institute, Dr. Andrew Brunner, MD of Mass General Cancer Center, Dr. Ruth O'Regan, MD of Wilmot Cancer Institute, and Dr. Deepak L. Bhatt, MD, MPH, MBA of MOUNT SINAI MANHATTAN HEART as they share insights on transforming patient care, together. Full videos coming soon! #patientcare #physician #pharmacist #pharmacy #clinicalpharmacist #qualitycare #patientsaftey #healthcareinnovation #oncologypharmacist #oncology #cardiovascularmedicine #cardiovascularpharmacist

As American Heart Month concludes, a powerful insight from Dr. Deepak L. Bhatt, MD, MPH, MBA of Mount Sinai Health System: "𝘐 𝘵𝘩𝘪𝘯𝘬 𝘪𝘧 𝘰𝘯𝘦 𝘤𝘢𝘯 𝘩𝘢𝘷𝘦 𝘢 𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘪𝘴𝘵 𝘰𝘯 𝘦𝘷𝘦𝘳𝘺 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘶𝘭𝘢𝘳 𝘤𝘢𝘳𝘦 𝘵𝘦𝘢𝘮, 𝘪𝘵 𝘳𝘦𝘢𝘭𝘭𝘺 𝘥𝘰𝘦𝘴 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘤𝘢𝘳𝘦." With cardiovascular patients often managing 10+ medications, pharmacists are essential team members who: ✅ Enhance patient safety ✅ Improve medication adherence ✅ Deliver value in both inpatient and outpatient settings   Watch Dr. Bhatt's full interview on the transformative impact of pharmacists in cardiovascular care. #AmericanHeartMonth #PharmacyLeadership #CardiovascularCare #CollaborativePractice #HeartMonth #ModernPharmacist

Our third issue of The Refill is here! In this issue, we discuss updates across the respiratory virus landscape and highlight a potentially transformative weight loss treatment. Follow the link below for more, and be sure to subscribe! Let us know in the comments: which update sticks out the most to you?

February 2025 presented a landscape of evolving health care challenges, ranging from novel approaches to managing substance withdrawal to pressing public health concerns. #Pharmacists play a crucial role in understanding and responding to these developments, ensuring patients remain informed about the latest advancements and potential threats. Learn more: https://bit.ly/4gXUubz

Looking to earn more CE credits? Pharmacy Times Continuing Education™ (PTCE) offers a wide range of educational resources to keep you up to date on the latest advancements in pharmacy. Create your free account today: https://ow.ly/eI9g50V8kxU #PharmacyEducation #FreeCE

The live illustration process captivated attendees last year at Oncology Pharmacists Connect! Faculty and participants alike told us how intriguing it was to see each discussion at OPC visualized in real-time. We're excited to bring this popular educational element back to OPC 2025 this June! Have you registered for #OPC25 yet? https://bit.ly/OPC2025 #oncologypharmacy #clinicalillustration #pharmacynotes #oncopharm

It is time we take the stigma away from proper and open discussions with women in perimenopause and menopause. Moreover, it is long overdue. Women have tried tackling this issue on their own without much care from our healthcare system. Most women that I’ve discussed this issue with have also bemoaned the lack of openness from grandmothers, mothers, etc… mainly because they were left in the dark. It was a game of trial and errors. Many still suffer in silence. Whenever it is discussed in a doctor’s office, many have also expressed frustration with the lack of care offered (if any was offered at all). Most women are dismissed or even told that it’s a normal biological function without any insight or direct patient care. This is unacceptable, and it is great to hear that Pharmacy Times has taken an interest. Much appreciated, and again, long overdue. There ARE pharmacists on the forefront of this, and we’ve worked alongside many women to address these issues for years now. #HealthEducator #MedicalWriter #Pharmacist #Perimenopause #Menopause #WomensHealth #Advocacy

The #FDA approved a hormone-free, copper intrauterine device (IUD; Miudella; Sebela Pharmaceuticals) for the prevention of pregnancy in people of reproductive potential for up to 3 years. With this approval, Miudella has become the first hormone-free #IUD to be FDA-approved in over 40 years. Learn more: https://bit.ly/4kaKyOO

Join the conversation with expert panel of oncology pharmacists including Ryan Haumschild PharmD, MS, MBA, CPEL; Brooke Peters, PharmD, BCOP; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO; Issam Hamadeh, PharmD, BCPS, BCOP; and Gabe Hinojosa, PharmD, BCOP as they uncover best practices for the implementation of bispecific antibody therapies in multiple myeloma care. Gain strategic perspectives on managing treatment-related adverse effects and addressing challenges in delivering care in community healthcare settings. Access the series link in the comments!

Eli Lilly and Company announced expanded access to #tirzepatide (Zepbound) with the launch of 7.5-mg and 10-mg single-dose vials priced at $499 through the new Zepbound Self Pay Journey Program. This program, offered exclusively through LillyDirect Self Pay Pharmacy Solutions, also includes reduced pricing for the existing 2.5 mg and 5 mg vials. Learn more: https://bit.ly/4kith6A